nodes	percent_of_prediction	percent_of_DWPC	metapath
Nafarelin—Vaginal discharge—Methotrexate—psoriatic arthritis	0.00705	0.00705	CcSEcCtD
Nafarelin—Acne—Dexamethasone—psoriatic arthritis	0.007	0.007	CcSEcCtD
Nafarelin—Acne—Betamethasone—psoriatic arthritis	0.007	0.007	CcSEcCtD
Nafarelin—Decreased appetite—Auranofin—psoriatic arthritis	0.00687	0.00687	CcSEcCtD
Nafarelin—Constipation—Auranofin—psoriatic arthritis	0.00676	0.00676	CcSEcCtD
Nafarelin—Herpes simplex—Dexamethasone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Nafarelin—Herpes simplex—Betamethasone—psoriatic arthritis	0.00639	0.00639	CcSEcCtD
Nafarelin—Urticaria—Auranofin—psoriatic arthritis	0.00628	0.00628	CcSEcCtD
Nafarelin—Acne—Prednisone—psoriatic arthritis	0.0061	0.0061	CcSEcCtD
Nafarelin—Interstitial lung disease—Methotrexate—psoriatic arthritis	0.00606	0.00606	CcSEcCtD
Nafarelin—Pleural effusion—Methotrexate—psoriatic arthritis	0.0056	0.0056	CcSEcCtD
Nafarelin—Pruritus—Auranofin—psoriatic arthritis	0.00559	0.00559	CcSEcCtD
Nafarelin—Increased appetite—Prednisolone—psoriatic arthritis	0.00545	0.00545	CcSEcCtD
Nafarelin—Diarrhoea—Auranofin—psoriatic arthritis	0.00541	0.00541	CcSEcCtD
Nafarelin—Affect lability—Prednisolone—psoriatic arthritis	0.00504	0.00504	CcSEcCtD
Nafarelin—Vomiting—Auranofin—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Nafarelin—Increased appetite—Triamcinolone—psoriatic arthritis	0.00502	0.00502	CcSEcCtD
Nafarelin—Increased appetite—Methylprednisolone—psoriatic arthritis	0.005	0.005	CcSEcCtD
Nafarelin—Rash—Auranofin—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Nafarelin—Dermatitis—Auranofin—psoriatic arthritis	0.00498	0.00498	CcSEcCtD
Nafarelin—Mood swings—Prednisolone—psoriatic arthritis	0.00485	0.00485	CcSEcCtD
Nafarelin—Eye pain—Dexamethasone—psoriatic arthritis	0.00474	0.00474	CcSEcCtD
Nafarelin—Eye pain—Betamethasone—psoriatic arthritis	0.00474	0.00474	CcSEcCtD
Nafarelin—Dry skin—Prednisolone—psoriatic arthritis	0.0047	0.0047	CcSEcCtD
Nafarelin—Nausea—Auranofin—psoriatic arthritis	0.00469	0.00469	CcSEcCtD
Nafarelin—Oliguria—Methotrexate—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Nafarelin—Herpes simplex—Methotrexate—psoriatic arthritis	0.00465	0.00465	CcSEcCtD
Nafarelin—Affect lability—Triamcinolone—psoriatic arthritis	0.00464	0.00464	CcSEcCtD
Nafarelin—Affect lability—Methylprednisolone—psoriatic arthritis	0.00463	0.00463	CcSEcCtD
Nafarelin—Increased appetite—Dexamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Nafarelin—Increased appetite—Betamethasone—psoriatic arthritis	0.00455	0.00455	CcSEcCtD
Nafarelin—Muscular weakness—Prednisolone—psoriatic arthritis	0.00452	0.00452	CcSEcCtD
Nafarelin—Mood swings—Triamcinolone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Nafarelin—Abdominal distension—Prednisolone—psoriatic arthritis	0.00446	0.00446	CcSEcCtD
Nafarelin—Mood swings—Methylprednisolone—psoriatic arthritis	0.00445	0.00445	CcSEcCtD
Nafarelin—Sweating increased—Prednisolone—psoriatic arthritis	0.00431	0.00431	CcSEcCtD
Nafarelin—Pulmonary embolism—Methotrexate—psoriatic arthritis	0.00429	0.00429	CcSEcCtD
Nafarelin—Affect lability—Dexamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Nafarelin—Affect lability—Betamethasone—psoriatic arthritis	0.00421	0.00421	CcSEcCtD
Nafarelin—Cystitis noninfective—Methotrexate—psoriatic arthritis	0.00419	0.00419	CcSEcCtD
Nafarelin—Muscular weakness—Triamcinolone—psoriatic arthritis	0.00416	0.00416	CcSEcCtD
Nafarelin—Muscular weakness—Methylprednisolone—psoriatic arthritis	0.00415	0.00415	CcSEcCtD
Nafarelin—Cystitis—Methotrexate—psoriatic arthritis	0.00414	0.00414	CcSEcCtD
Nafarelin—Abdominal distension—Triamcinolone—psoriatic arthritis	0.0041	0.0041	CcSEcCtD
Nafarelin—Abdominal distension—Methylprednisolone—psoriatic arthritis	0.00409	0.00409	CcSEcCtD
Nafarelin—Mood swings—Dexamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Nafarelin—Mood swings—Betamethasone—psoriatic arthritis	0.00405	0.00405	CcSEcCtD
Nafarelin—Weight increased—Prednisolone—psoriatic arthritis	0.00403	0.00403	CcSEcCtD
Nafarelin—Sweating increased—Triamcinolone—psoriatic arthritis	0.00397	0.00397	CcSEcCtD
Nafarelin—Increased appetite—Prednisone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Nafarelin—Sweating increased—Methylprednisolone—psoriatic arthritis	0.00396	0.00396	CcSEcCtD
Nafarelin—Dry skin—Dexamethasone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Nafarelin—Dry skin—Betamethasone—psoriatic arthritis	0.00392	0.00392	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisolone—psoriatic arthritis	0.00389	0.00389	CcSEcCtD
Nafarelin—Neoplasm—Methotrexate—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Nafarelin—Bladder pain—Methotrexate—psoriatic arthritis	0.00388	0.00388	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisolone—psoriatic arthritis	0.00387	0.00387	CcSEcCtD
Nafarelin—Conjunctivitis—Prednisolone—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Nafarelin—Gynaecomastia—Methotrexate—psoriatic arthritis	0.00384	0.00384	CcSEcCtD
Nafarelin—Muscular weakness—Dexamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Nafarelin—Muscular weakness—Betamethasone—psoriatic arthritis	0.00377	0.00377	CcSEcCtD
Nafarelin—Weight increased—Triamcinolone—psoriatic arthritis	0.00371	0.00371	CcSEcCtD
Nafarelin—Weight increased—Methylprednisolone—psoriatic arthritis	0.0037	0.0037	CcSEcCtD
Nafarelin—Affect lability—Prednisone—psoriatic arthritis	0.00367	0.00367	CcSEcCtD
Nafarelin—Sweating increased—Dexamethasone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Nafarelin—Sweating increased—Betamethasone—psoriatic arthritis	0.0036	0.0036	CcSEcCtD
Nafarelin—Acute coronary syndrome—Triamcinolone—psoriatic arthritis	0.00358	0.00358	CcSEcCtD
Nafarelin—Acute coronary syndrome—Methylprednisolone—psoriatic arthritis	0.00357	0.00357	CcSEcCtD
Nafarelin—Myocardial infarction—Triamcinolone—psoriatic arthritis	0.00356	0.00356	CcSEcCtD
Nafarelin—Myocardial infarction—Methylprednisolone—psoriatic arthritis	0.00355	0.00355	CcSEcCtD
Nafarelin—Conjunctivitis—Triamcinolone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Nafarelin—Mood swings—Prednisone—psoriatic arthritis	0.00353	0.00353	CcSEcCtD
Nafarelin—Epistaxis—Triamcinolone—psoriatic arthritis	0.00343	0.00343	CcSEcCtD
Nafarelin—Dry skin—Prednisone—psoriatic arthritis	0.00341	0.00341	CcSEcCtD
Nafarelin—Weight increased—Dexamethasone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Nafarelin—Weight increased—Betamethasone—psoriatic arthritis	0.00336	0.00336	CcSEcCtD
Nafarelin—Weight decreased—Betamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Nafarelin—Weight decreased—Dexamethasone—psoriatic arthritis	0.00334	0.00334	CcSEcCtD
Nafarelin—Muscular weakness—Prednisone—psoriatic arthritis	0.00328	0.00328	CcSEcCtD
Nafarelin—Rhinitis—Triamcinolone—psoriatic arthritis	0.00327	0.00327	CcSEcCtD
Nafarelin—Rhinitis—Methylprednisolone—psoriatic arthritis	0.00326	0.00326	CcSEcCtD
Nafarelin—Acute coronary syndrome—Betamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Nafarelin—Acute coronary syndrome—Dexamethasone—psoriatic arthritis	0.00325	0.00325	CcSEcCtD
Nafarelin—Abdominal distension—Prednisone—psoriatic arthritis	0.00324	0.00324	CcSEcCtD
Nafarelin—Myocardial infarction—Dexamethasone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Nafarelin—Myocardial infarction—Betamethasone—psoriatic arthritis	0.00323	0.00323	CcSEcCtD
Nafarelin—Conjunctivitis—Dexamethasone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Nafarelin—Conjunctivitis—Betamethasone—psoriatic arthritis	0.0032	0.0032	CcSEcCtD
Nafarelin—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.00318	0.00318	CcSEcCtD
Nafarelin—Sweating increased—Prednisone—psoriatic arthritis	0.00314	0.00314	CcSEcCtD
Nafarelin—Mood swings—Methotrexate—psoriatic arthritis	0.00295	0.00295	CcSEcCtD
Nafarelin—Weight increased—Prednisone—psoriatic arthritis	0.00293	0.00293	CcSEcCtD
Nafarelin—Weight decreased—Prednisone—psoriatic arthritis	0.00291	0.00291	CcSEcCtD
Nafarelin—Depression—Prednisone—psoriatic arthritis	0.00286	0.00286	CcSEcCtD
Nafarelin—Mental disorder—Methylprednisolone—psoriatic arthritis	0.00285	0.00285	CcSEcCtD
Nafarelin—Malnutrition—Methylprednisolone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Nafarelin—Acute coronary syndrome—Prednisone—psoriatic arthritis	0.00283	0.00283	CcSEcCtD
Nafarelin—Myocardial infarction—Prednisone—psoriatic arthritis	0.00281	0.00281	CcSEcCtD
Nafarelin—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00278	0.00278	CcSEcCtD
Nafarelin—Vertigo—Prednisolone—psoriatic arthritis	0.00277	0.00277	CcSEcCtD
Nafarelin—Convulsion—Prednisolone—psoriatic arthritis	0.00267	0.00267	CcSEcCtD
Nafarelin—Alopecia—Dexamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Nafarelin—Alopecia—Betamethasone—psoriatic arthritis	0.00261	0.00261	CcSEcCtD
Nafarelin—Vertigo—Triamcinolone—psoriatic arthritis	0.00255	0.00255	CcSEcCtD
Nafarelin—Vertigo—Methylprednisolone—psoriatic arthritis	0.00254	0.00254	CcSEcCtD
Nafarelin—Oedema—Prednisolone—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Nafarelin—Dysuria—Methotrexate—psoriatic arthritis	0.00252	0.00252	CcSEcCtD
Nafarelin—Shock—Prednisolone—psoriatic arthritis	0.00248	0.00248	CcSEcCtD
Nafarelin—Convulsion—Triamcinolone—psoriatic arthritis	0.00246	0.00246	CcSEcCtD
Nafarelin—Convulsion—Methylprednisolone—psoriatic arthritis	0.00245	0.00245	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.00243	0.00243	CcSEcCtD
Nafarelin—Myalgia—Triamcinolone—psoriatic arthritis	0.00242	0.00242	CcSEcCtD
Nafarelin—Myalgia—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Nafarelin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00241	0.00241	CcSEcCtD
Nafarelin—Depression—Methotrexate—psoriatic arthritis	0.00239	0.00239	CcSEcCtD
Nafarelin—Conjunctivitis—Methotrexate—psoriatic arthritis	0.00233	0.00233	CcSEcCtD
Nafarelin—Oedema—Triamcinolone—psoriatic arthritis	0.00232	0.00232	CcSEcCtD
Nafarelin—Vertigo—Dexamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Nafarelin—Vertigo—Betamethasone—psoriatic arthritis	0.00231	0.00231	CcSEcCtD
Nafarelin—Shock—Triamcinolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Nafarelin—Insomnia—Prednisolone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Nafarelin—Alopecia—Prednisone—psoriatic arthritis	0.00228	0.00228	CcSEcCtD
Nafarelin—Shock—Methylprednisolone—psoriatic arthritis	0.00227	0.00227	CcSEcCtD
Nafarelin—Epistaxis—Methotrexate—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Nafarelin—Paraesthesia—Prednisolone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Nafarelin—Mental disorder—Prednisone—psoriatic arthritis	0.00226	0.00226	CcSEcCtD
Nafarelin—Malnutrition—Prednisone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Nafarelin—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00224	0.00224	CcSEcCtD
Nafarelin—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Nafarelin—Convulsion—Betamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Nafarelin—Convulsion—Dexamethasone—psoriatic arthritis	0.00223	0.00223	CcSEcCtD
Nafarelin—Myalgia—Betamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Nafarelin—Myalgia—Dexamethasone—psoriatic arthritis	0.00219	0.00219	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00211	0.00211	CcSEcCtD
Nafarelin—Oedema—Dexamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Nafarelin—Oedema—Betamethasone—psoriatic arthritis	0.0021	0.0021	CcSEcCtD
Nafarelin—Insomnia—Triamcinolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Nafarelin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00209	0.00209	CcSEcCtD
Nafarelin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Nafarelin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00208	0.00208	CcSEcCtD
Nafarelin—Shock—Betamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Nafarelin—Shock—Dexamethasone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Nafarelin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00207	0.00207	CcSEcCtD
Nafarelin—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Nafarelin—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.00203	0.00203	CcSEcCtD
Nafarelin—Vertigo—Prednisone—psoriatic arthritis	0.00201	0.00201	CcSEcCtD
Nafarelin—Anorexia—Betamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Nafarelin—Anorexia—Dexamethasone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Nafarelin—Urticaria—Prednisolone—psoriatic arthritis	0.002	0.002	CcSEcCtD
Nafarelin—Convulsion—Prednisone—psoriatic arthritis	0.00194	0.00194	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Nafarelin—Myalgia—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Nafarelin—Arthralgia—Prednisone—psoriatic arthritis	0.00191	0.00191	CcSEcCtD
Nafarelin—Alopecia—Methotrexate—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Nafarelin—Insomnia—Dexamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Nafarelin—Insomnia—Betamethasone—psoriatic arthritis	0.0019	0.0019	CcSEcCtD
Nafarelin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Nafarelin—Paraesthesia—Betamethasone—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Nafarelin—Mental disorder—Methotrexate—psoriatic arthritis	0.00189	0.00189	CcSEcCtD
Nafarelin—Malnutrition—Methotrexate—psoriatic arthritis	0.00187	0.00187	CcSEcCtD
Nafarelin—Urticaria—Triamcinolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Nafarelin—Urticaria—Methylprednisolone—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Nafarelin—Dysgeusia—Methotrexate—psoriatic arthritis	0.00184	0.00184	CcSEcCtD
Nafarelin—Oedema—Prednisone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Nafarelin—Decreased appetite—Betamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Nafarelin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00183	0.00183	CcSEcCtD
Nafarelin—Shock—Prednisone—psoriatic arthritis	0.0018	0.0018	CcSEcCtD
Nafarelin—Hyperhidrosis—Prednisone—psoriatic arthritis	0.00177	0.00177	CcSEcCtD
Nafarelin—Anorexia—Prednisone—psoriatic arthritis	0.00174	0.00174	CcSEcCtD
Nafarelin—Vertigo—Methotrexate—psoriatic arthritis	0.00168	0.00168	CcSEcCtD
Nafarelin—Urticaria—Betamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Nafarelin—Urticaria—Dexamethasone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Nafarelin—Dizziness—Prednisolone—psoriatic arthritis	0.00167	0.00167	CcSEcCtD
Nafarelin—Asthenia—Triamcinolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Nafarelin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Nafarelin—Insomnia—Prednisone—psoriatic arthritis	0.00166	0.00166	CcSEcCtD
Nafarelin—Paraesthesia—Prednisone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Nafarelin—Pruritus—Triamcinolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Nafarelin—Pruritus—Methylprednisolone—psoriatic arthritis	0.00164	0.00164	CcSEcCtD
Nafarelin—Convulsion—Methotrexate—psoriatic arthritis	0.00162	0.00162	CcSEcCtD
Nafarelin—Arthralgia—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Nafarelin—Chest pain—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Nafarelin—Myalgia—Methotrexate—psoriatic arthritis	0.0016	0.0016	CcSEcCtD
Nafarelin—Decreased appetite—Prednisone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Nafarelin—Rash—Prednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Nafarelin—Dermatitis—Prednisolone—psoriatic arthritis	0.00159	0.00159	CcSEcCtD
Nafarelin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Nafarelin—Headache—Prednisolone—psoriatic arthritis	0.00158	0.00158	CcSEcCtD
Nafarelin—Constipation—Prednisone—psoriatic arthritis	0.00157	0.00157	CcSEcCtD
Nafarelin—Dizziness—Triamcinolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Nafarelin—Dizziness—Methylprednisolone—psoriatic arthritis	0.00153	0.00153	CcSEcCtD
Nafarelin—Asthenia—Dexamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Nafarelin—Asthenia—Betamethasone—psoriatic arthritis	0.00151	0.00151	CcSEcCtD
Nafarelin—Nausea—Prednisolone—psoriatic arthritis	0.0015	0.0015	CcSEcCtD
Nafarelin—Pruritus—Betamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Nafarelin—Pruritus—Dexamethasone—psoriatic arthritis	0.00149	0.00149	CcSEcCtD
Nafarelin—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.00148	0.00148	CcSEcCtD
Nafarelin—Vomiting—Triamcinolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Nafarelin—Vomiting—Methylprednisolone—psoriatic arthritis	0.00147	0.00147	CcSEcCtD
Nafarelin—Rash—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Nafarelin—Dermatitis—Triamcinolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Nafarelin—Anorexia—Methotrexate—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Nafarelin—Rash—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Nafarelin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.00146	0.00146	CcSEcCtD
Nafarelin—Urticaria—Prednisone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Nafarelin—Headache—Triamcinolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Nafarelin—Headache—Methylprednisolone—psoriatic arthritis	0.00145	0.00145	CcSEcCtD
Nafarelin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Nafarelin—Diarrhoea—Betamethasone—psoriatic arthritis	0.00144	0.00144	CcSEcCtD
Nafarelin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Nafarelin—Dizziness—Dexamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Nafarelin—Dizziness—Betamethasone—psoriatic arthritis	0.00139	0.00139	CcSEcCtD
Nafarelin—Insomnia—Methotrexate—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Nafarelin—Nausea—Triamcinolone—psoriatic arthritis	0.00138	0.00138	CcSEcCtD
Nafarelin—Paraesthesia—Methotrexate—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Nafarelin—Nausea—Methylprednisolone—psoriatic arthritis	0.00137	0.00137	CcSEcCtD
Nafarelin—Dyspnoea—Methotrexate—psoriatic arthritis	0.00136	0.00136	CcSEcCtD
Nafarelin—Vomiting—Dexamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Nafarelin—Vomiting—Betamethasone—psoriatic arthritis	0.00134	0.00134	CcSEcCtD
Nafarelin—Decreased appetite—Methotrexate—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Nafarelin—Rash—Betamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Nafarelin—Rash—Dexamethasone—psoriatic arthritis	0.00133	0.00133	CcSEcCtD
Nafarelin—Dermatitis—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Nafarelin—Dermatitis—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Nafarelin—Headache—Dexamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Nafarelin—Headache—Betamethasone—psoriatic arthritis	0.00132	0.00132	CcSEcCtD
Nafarelin—Asthenia—Prednisone—psoriatic arthritis	0.00131	0.00131	CcSEcCtD
Nafarelin—Pruritus—Prednisone—psoriatic arthritis	0.00129	0.00129	CcSEcCtD
Nafarelin—Diarrhoea—Prednisone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Nafarelin—Nausea—Betamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Nafarelin—Nausea—Dexamethasone—psoriatic arthritis	0.00125	0.00125	CcSEcCtD
Nafarelin—Urticaria—Methotrexate—psoriatic arthritis	0.00122	0.00122	CcSEcCtD
Nafarelin—Dizziness—Prednisone—psoriatic arthritis	0.00121	0.00121	CcSEcCtD
Nafarelin—Vomiting—Prednisone—psoriatic arthritis	0.00116	0.00116	CcSEcCtD
Nafarelin—Rash—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Nafarelin—Dermatitis—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Nafarelin—Headache—Prednisone—psoriatic arthritis	0.00115	0.00115	CcSEcCtD
Nafarelin—Asthenia—Methotrexate—psoriatic arthritis	0.0011	0.0011	CcSEcCtD
Nafarelin—Nausea—Prednisone—psoriatic arthritis	0.00109	0.00109	CcSEcCtD
Nafarelin—Pruritus—Methotrexate—psoriatic arthritis	0.00108	0.00108	CcSEcCtD
Nafarelin—Diarrhoea—Methotrexate—psoriatic arthritis	0.00105	0.00105	CcSEcCtD
Nafarelin—Dizziness—Methotrexate—psoriatic arthritis	0.00101	0.00101	CcSEcCtD
Nafarelin—Vomiting—Methotrexate—psoriatic arthritis	0.000973	0.000973	CcSEcCtD
Nafarelin—Rash—Methotrexate—psoriatic arthritis	0.000964	0.000964	CcSEcCtD
Nafarelin—Dermatitis—Methotrexate—psoriatic arthritis	0.000964	0.000964	CcSEcCtD
Nafarelin—Headache—Methotrexate—psoriatic arthritis	0.000958	0.000958	CcSEcCtD
Nafarelin—Nausea—Methotrexate—psoriatic arthritis	0.000909	0.000909	CcSEcCtD
